Literature DB >> 29685899

Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis.

Anne E Visser1, James P K Rooney2, Fabrizio D'Ovidio3, Jan H Veldink1, Leonard H van den Berg1, Henk-Jan Westeneng1, Roel C H Vermeulen4, Ettore Beghi5, Adriano Chiò3, Giancarlo Logroscino6,7, Orla Hardiman2.   

Abstract

OBJECTIVE: To investigate the association between physical activity (PA) and amyotrophic lateral sclerosis (ALS) in population-based case-control studies in three European countries using a validated and harmonised questionnaire.
METHODS: Patients with incident ALS and controls were recruited from five population-based registers in The Netherlands, Ireland and Italy. Demographic and data regarding educational level, smoking, alcohol habits and lifetime PA levels in both leisure and work time were gathered by questionnaire, and quantified using metabolic equivalent of task scores. Logistic regression models adjusting for PA-related factors were used to determine the association between PA and ALS risk, and forest plots were used to visualise heterogeneity between regions.
RESULTS: 1557 patients and 2922 controls were included. We found a linear association between ALS and PA in leisure time (OR 1.07, P=0.01) and occupational activities (OR 1.06, P<0.001), and all activities combined (OR 1.06, P<0.001), with some heterogeneity between regions: the most evident association was seen in the Irish and Italian cohorts. After adjustment for other occupational exposures or exclusion of patients with a C9orf72 mutation, the ORs remained similar.
CONCLUSION: We provide new class I evidence for a positive association between PA and risk of ALS in a large multicentre study using harmonised methodology to objectively quantify PA levels, with some suggestions for population differences. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Mesh:

Year:  2018        PMID: 29685899     DOI: 10.1136/jnnp-2017-317724

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Recumbent stepping aerobic exercise in amyotrophic lateral sclerosis: a pilot study.

Authors:  Anjali Sivaramakrishnan; Sangeetha Madhavan
Journal:  Neurol Sci       Date:  2019-02-04       Impact factor: 3.307

2.  Common genetic basis of ALS patients and soccer players may contribute to disease risk.

Authors:  Sigal Ben-Zaken; Beatrice Nefussy; Yoav Meckel; Alon Eliakim; Dan Nemet; Marc Gotkine; Dana Lorber; Aviva Zeev; Vivian E Drory
Journal:  Neurol Sci       Date:  2022-03-05       Impact factor: 3.307

3.  From Physiological Properties to Selective Vulnerability of Motor Units in Amyotrophic Lateral Sclerosis.

Authors:  Marcin Bączyk; Marin Manuel; Francesco Roselli; Daniel Zytnicki
Journal:  Adv Neurobiol       Date:  2022

4.  Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis.

Authors:  Antonio Canosa; Fabrizio D'Ovidio; Andrea Calvo; Cristina Moglia; Umberto Manera; Maria Claudia Torrieri; Rosario Vasta; Angelina Cistaro; Silvia Gallo; Barbara Iazzolino; Flavio Mariano Nobili; Federico Casale; Adriano Chiò; Marco Pagani
Journal:  Neuroimage Clin       Date:  2020-06-12       Impact factor: 4.881

Review 5.  Disease-modifying effects of metabolic perturbations in ALS/FTLD.

Authors:  Ali Jawaid; Romesa Khan; Magdalini Polymenidou; Paul E Schulz
Journal:  Mol Neurodegener       Date:  2018-12-04       Impact factor: 14.195

6.  Mortality Among Professional American-Style Football Players and Professional American Baseball Players.

Authors:  Vy T Nguyen; Ross D Zafonte; Jarvis T Chen; Kalé Z Kponee-Shovein; Sabrina Paganoni; Alvaro Pascual-Leone; Frank E Speizer; Aaron L Baggish; Herman A Taylor; Lee M Nadler; Theodore K Courtney; Ann Connor; Marc G Weisskopf
Journal:  JAMA Netw Open       Date:  2019-05-03

7.  Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.

Authors:  Trine Toft Sørensen; Erzsébet Horváth-Puhó; Mette Nørgaard; Vera Ehrenstein; Victor W Henderson
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

Review 8.  Uses for humanised mouse models in precision medicine for neurodegenerative disease.

Authors:  Remya R Nair; Silvia Corrochano; Samanta Gasco; Charlotte Tibbit; David Thompson; Cheryl Maduro; Zeinab Ali; Pietro Fratta; Abraham Acevedo Arozena; Thomas J Cunningham; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2019-06-15       Impact factor: 2.957

Review 9.  Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment.

Authors:  Sarah Schram; Jeffrey A Loeb; Fei Song
Journal:  J Neuroinflammation       Date:  2020-06-06       Impact factor: 8.322

Review 10.  Retrotransposons in the development and progression of amyotrophic lateral sclerosis.

Authors:  Abigail L Savage; Gerald G Schumann; Gerome Breen; Vivien J Bubb; Ammar Al-Chalabi; John P Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.